Koninklijke Philips logged a 5.9% change during today's evening session, and is now trading at a price of $22.2 per share.
Koninklijke Philips returned gains of 51.0% last year, with its stock price reaching a high of $23.3 and a low of $12.96. Over the same period, the stock outperformed the S&P 500 index by 30.2%. More recently, the company's 50-day average price was $19.79. Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. Based in Amsterdam, Netherlands, the large-cap Health Care company has 70,741 full time employees. Koninklijke Philips has not offered a regular dividend during the last year.
The Business Is Unprofitable and Its Balance Sheet Is Highly Leveraged:
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|
| Revenue (MM) | $18,121 | $18,121 | $17,313 | $17,313 | $17,827 | $17,827 |
| Revenue Growth | n/a | 0.0% | -4.46% | 0.0% | 2.97% | 0.0% |
| Operating Margins | 9% | 9% | 8% | 7% | 3% | -9% |
| Net Margins | 10% | 8% | 9% | 26% | 25% | -4% |
| Net Income (MM) | $1,870 | $1,512 | $1,512 | $4,527 | $4,527 | -$782 |
| Net Interest Expense (MM) | $222 | $196 | $196 | $173 | $235 | $235 |
| Depreciation & Amort. (MM) | $1,089 | $1,343 | $1,462 | $1,462 | $1,602 | $1,602 |
| Current Ratio | 1.27 | 1.21 | 1.45 | 1.45 | 1.3 | 1.29 |
| Total Debt (MM) | $8,205 | $9,100 | $10,005 | $10,515 | $11,333 | $11,333 |
| Net Debt / EBITDA | 2.23 | 2.42 | 2.4 | 2.67 | 4.19 | 139.19 |
Koninklijke Philips does not have a meaningful trailing P/E ratio since its earnings per share are currently in the red. Based on its EPS guidance of $1.61, the company has a forward P/E ratio of 12.3. In comparison, the average P/E ratio for the Health Care sector is 30.21. On the other hand, the market is undervaluing Koninklijke Philips in terms of its equity because its P/B ratio is 1.68. In comparison, the sector average is 4.08.
There's an Analyst Consensus that Shares Are Overpriced for Koninklijke Philips:
The 3 analysts following Koninklijke Philips have set target prices ranging from $18.56 to $22.07 per share, for an average of $19.8 with a underperform rating. As of April 2023, the company is trading -0.1% away from its average target price, indicating that there is an analyst belief that shares are overpriced.
The largest shareholder is Exor N.V., whose 15% stake in the company is worth $3,092,404,672.
